IRIS
STELITANO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.083
AS - Asia 972
EU - Europa 707
SA - Sud America 199
AF - Africa 71
OC - Oceania 9
Totale 3.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.041
CN - Cina 320
SG - Singapore 236
IE - Irlanda 145
BR - Brasile 143
HK - Hong Kong 134
IT - Italia 127
RU - Federazione Russa 125
VN - Vietnam 114
DE - Germania 73
GB - Regno Unito 57
FR - Francia 55
ZA - Sudafrica 50
IN - India 49
FI - Finlandia 29
BD - Bangladesh 22
AT - Austria 20
AR - Argentina 19
MX - Messico 18
CA - Canada 16
JP - Giappone 16
ID - Indonesia 11
IQ - Iraq 11
NL - Olanda 11
PL - Polonia 11
SE - Svezia 11
ES - Italia 10
EG - Egitto 9
UA - Ucraina 9
AU - Australia 8
CO - Colombia 8
CL - Cile 7
TR - Turchia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
LT - Lituania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
KR - Corea 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
JO - Giordania 3
TN - Tunisia 3
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BJ - Benin 1
CR - Costa Rica 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
TW - Taiwan 1
Totale 3.041
Salva come PNG Salva come JPEG
Città #
San Jose 150
Hong Kong 129
Ashburn 119
Singapore 119
Dublin 115
Dallas 90
Beijing 75
Chandler 71
Boardman 55
Ho Chi Minh City 45
Johannesburg 38
Los Angeles 38
Lauterbourg 37
Shanghai 34
Munich 32
New York 31
Pavia 28
Redondo Beach 24
Hanoi 23
Helsinki 21
Ann Arbor 20
Milan 20
Moscow 20
São Paulo 16
Lawrence 15
Princeton 15
The Dalles 15
Vienna 15
Medford 14
Tokyo 14
Orem 13
Santa Clara 13
Chicago 12
Nanjing 12
Shenyang 11
Menlo Park 9
Nuremberg 9
Warsaw 9
Cape Town 8
Chennai 8
Haiphong 8
Nanchang 8
Turku 8
Wilmington 8
Atlanta 7
Brooklyn 7
Corteolona 7
Dearborn 7
Dhaka 7
Florence 7
Hyderabad 7
Montreal 7
Stockholm 7
Washington 7
Boston 6
Buffalo 6
Cinisello Balsamo 6
Denver 6
Frankfurt am Main 6
Guangzhou 6
London 6
Mumbai 6
Seattle 6
Amsterdam 5
Changsha 5
Columbus 5
Da Nang 5
Fairfield 5
Falkenstein 5
Hangzhou 5
Mexico City 5
Shenzhen 5
Tashkent 5
Turin 5
Worcester Park 5
Brasília 4
Cagliari 4
Chongqing 4
Council Bluffs 4
Coventry 4
Curitiba 4
Delhi 4
Erbil 4
Istanbul 4
Jiaxing 4
Palermo 4
Poplar 4
Quito 4
Recife 4
Rio de Janeiro 4
San Genesio ed Uniti 4
Secaucus 4
Tianjin 4
Amman 3
Armidale 3
Brighton 3
Caracas 3
Charlotte 3
Cologne 3
Dubai 3
Totale 1.851
Salva come PNG Salva come JPEG
Nome #
Characterization of mycobacterial enzymes as targets for potential antitubercular compounds. 124
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 121
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents 112
From virulence factors to drug development: MbtI as an effective Mycobacterium tuberculosis target 109
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents 106
Improve protection to prevent infections: application of reverse vaccinology against cystic fibrosis pathogens. 105
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 104
Targeting iron uptake pathway for the development of novel antitubercular drugs. 100
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 98
Mycobacterium abscessus siderophores biosynthesis as a target to inhibit the iron uptake mechanism 92
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 88
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 84
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MbtI from Mycobacterium tuberculosis. 84
Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation 81
Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach 81
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 80
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. 78
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors. 78
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 75
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand? 72
Structural insights for the development of novel antituberculars targeting the iron uptake pathway. 72
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 72
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 70
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 69
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 69
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents 69
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI. 61
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis MbtI and MPtpB 60
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 60
Phage therapy: an alternative approach to combating multi-drug-resistant bacterial infections in cystic fibrosis 59
Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents 58
Artificial Intuition and accelerating the process of antimicrobial drug discovery 57
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 57
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy 56
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 55
Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis. 53
Chapter 28. Multi-target Compounds for Tuberculosis 49
Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections 45
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors. 40
Polymersomes as selective drug delivery carriers for innovative anti-TB agents. 34
Structural and biochemical investigations into the binding mode of furan-based inhibitors of MbtI from M. tuberculosis. 32
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity. 30
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity 29
Uncovering insights into the biology of Mycobacterium tuberculosis using genetic tools 14
Advancing the antituberculosis activity of nitropicolinic acids and amides 11
Totale 3.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.053
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 1 2
2021/2022109 0 0 0 40 2 1 4 4 12 8 7 31
2022/2023283 18 29 11 10 14 20 0 21 141 1 15 3
2023/2024325 26 52 19 41 24 55 31 16 1 22 9 29
2024/2025763 37 55 20 12 31 21 65 52 205 41 73 151
2025/20261.533 145 89 186 197 208 71 291 107 141 98 0 0
Totale 3.153